Leah J. Hogdal

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

Marina Konopleva, Daniel A. Pollyea, Jalaja Potluri et al. · Cancer Discovery · 2016 · 1.1K citations · Full text

Medicine, Hematology, Pharmacology +17

Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

Rongqing Pan, Leah J. Hogdal, Juliana M. Benito et al. · Cancer Discovery · 2013 · 735 citations · Full text

Life Sciences, Oncology, Pharmacology +17

A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia

Haley E. Ramsey, Melissa A. Fischer, Taekyu Lee et al. · Cancer Discovery · 2018 · 381 citations · Full text

Medicine, Oncology, Pharmacology +16

Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax

Joan Montero, Jason Stephansky, Tianyu Cai et al. · Cancer Discovery · 2016 · 209 citations · Full text

Medicine, Cancer Biology, Oncology +14

MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199

Juliana M. Benito, Laura Godfrey, Kensuke Kojima et al. · Cell Reports · 2015 · 155 citations · Full text

Life Sciences, Molecular Biology, Oncology +16